Clinical Trial Update: Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts [Phase 1, Phase 2]

View source ↗

Summary

Exploratory study examining aerosol inhalation of FB2001 for post-exposure prophylaxis of COVID-19 among close contacts; currently in Phase 1/Phase 2 with unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Close Contact Transmission of COVID-19

Drugs mentioned

• FB2001

Snippet

Sponsor: Ruijin Hospital | Conditions: Close Contact Transmission | Phase 1, Phase 2 | Status: UNKNOWN